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Abstract  
Introduction: The intake of folic acid before conception and during the first trimester of pregnancy can prevent spina bifida. This paper describes 
folic acid intake in women in Gulu district in northern Uganda. Methods: Structured interviews were held with 394 women attending antenatal 
care (ANC), 15 mothers of children with spina bifida, and 35 health workers in 2012 and 2013. SPSS16 was used for data analysis. Results: 1/4 
mothers of children with spina bifida took folic acid during late pregnancy, none preconception. None had knowledge about folic acid and spina 
bifida prevention. 33.5% of women attending ANC had ever heard about spina bifida, 1% knew folic acid intake can prevent spina bifida. 42.4% 
took folic acid supplements in late pregnancy, 8.1% during the first trimester, none preconception. All women said to have eaten food rich in folic 
acid. None were aware about fortified foods. 7% of health workers understood the importance of early folic acid intake. All health workers 
recommended folic acid intake to women attending ANC. 20% of the health workers and 25% of the women said folic acid supplements are not 
always available. Conclusion: Folic acid intake is limited in northern Uganda. This is attributed to limited education and understanding of women 
and health workers about the importance of early folic acid intake, late presentation of women at ANC, poor supply chain and dilapidated health 
services caused by war and poverty. A combination of food fortification, sensitization of health workers, women, and improving folic acid supply is 
recommended. 
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Introduction 
 
Spina Bifida is a neural tube defect (NTD) caused by a fault in the 
development of the central nervous system in the first 25 days of 
the pregnancy [1]. The worldwide incidence varies between 0.17 
and 6.39 per 1000 live births [2-5]. An estimated 1,400 children are 
born with spina bifida in Uganda annually [6]. Incidence and 
prevalence rates in Uganda are probably higher due to absence of 
folate consumption by pregnant women, lack of pre-natal care [7], 
absence of secondary prevention [8], higher exposure to 
environmental risk factors such as dioxins [9] and fumonisins intake 
[10-12], and high birth rates [6]. 
  
Folic acid (also referred to as folate, folacin, Vitamin B9, 
pteroylglutamic acid), delivered through supplementation or 
fortification (or other strategies) prevents the first occurrence of 
NTDs [13, 14] as well as the recurrence of NTDs in families with 
previous NTD-affected pregnancy [15]. The World Health 
Organization (WHO) recommends that all women of childbearing 
age consume 400 μg of folic acid daily and that women with 
pregnancies previously affected by NTDs consume 5000 μg of FA 
daily [16]. Women should consume these amounts in the peri-
conceptional period as it takes 8 weeks to reach the optimal level of 
serum folate [17]. Supplements are an effective way to prevent 
spina bifida, but there is low compliance [18, 19]. Countries 
fortifying the flour with at least folic acid see an average 46% 
reduction of NTD prevalence [20]. 
  
In Uganda only 17% of pregnant women attend antenatal care 
(ANC) before the fourth month of pregnancy [21]. Of those who do 
attend ANC women are 5.5 months pregnant (median) when they 
come for their first visit. The Ugandan Government advises intake of 
folic acid following WHO recommendations [22]. In a study in rural 
Uganda 13.2% of women attending ANC took folic acid during 
pregnancy [23]. The health indicators for the northern region are 
worse compared to the rest of the country [21], partly attributed to 
conflict between the Government of Uganda and the Lord's 
Resistance Army (1986 - 2006), which displaced an estimated 2 
million people into internally displaced people (IDP) camps [24]. 
Lack of human resources, limited knowledge, shortages of medical 
supplies and inadequate infrastructure hamper implementation of 
quality health services [25, 26]. The study area, Gulu district had 
410,673 inhabitants with 15,992 deliveries, 33% of pregnant 
women attending 4 ANC visits, and 72% of staff positions filled in 
health facilities in 2012 [27]. Uganda passed a national legislation to 
require fortification of wheat and maize flours with iron, zinc, folic 
acid and other B vitamins in 2011. The legislation requires 
fortification of white and brown wheat flours and maize products 
produced in Uganda as well as those imported to Uganda. Whilst 
some flour producers have started fortifying their products, not all 
are compliant [28]. 
  
  
Methods 
 
Quantitative and qualitative descriptive cross-sectional survey 
methods were employed to collect data on folic acid intake and 
understanding of its effect on the prevention of spina bifida in Gulu 
district. In total 15 mothers of children with spina bifida were asked 
about folic acid intake during their pregnancy. In addition 394 
women in reproductive age group (15-49 years) attending ANC 
were surveyed. As well 35 health workers, working at ANCat 
government health facilities were interviewed. The 394 women and 
35 health workers were selected by simple random sampling at 
antenatal clinics. The mothers of children with spina bifida were 
purposefully selected from a mobile specialist review clinic for 
children with neurological conditions in Gulu. The data collection 
tools included semi structured questionnaires and interviews. Data 
was entered and analyzed using SPSS16. 
  
  
Results 
 
Study participants had a median age of 29 years, the majority was 
married, Christian, completed primary school, and had 3 or 4 
children. Table 1 shows the demographic characteristics of 15 
mothers of children with spina bifida, 394 women in reproductive 
age attending antenatal clinics, and 35 health workers. Of the 15 
mothers of children with spina bifida interviewed, only a fourth took 
folic acid supplements during pregnancy, and none of them took 
these in the first semester (table 2). All mothers of children with 
spina bifida had never heard about spina bifida before they gave 
birth to their child, and had not known about the preventative effect 
of folic acid. All said they ate vegetables rich in folic acid such as 
spinach and avocado before and during pregnancy, but not on a 
daily basis. Intake varied during the year depending on whether 
they were dependent on food handouts during their time in the IDP 
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camps, and/or the season and availability. None had heard about 
food fortification before having a child with spina bifida. 
  
Of the women attending ANC, 65.8% lived within 2 kilometers of 
the health facility (259), 23.4% (92) within 5kms, and 11% (43) 
beyond 5kms. 50.5% (197) took folic acid, none before pregnancy, 
and only 8.1% (32) during the first trimester of pregnancy (table 2). 
In total 33.5% (132/394) of the women attending ANC had ever 
heard about spina bifida. Only 1% (2) knew about the preventative 
effect of folic acid intake. Women who had knowledge about spina 
bifida were more likely to take folic acid than those who did not 
(table 3, p<0.001). All women said they ate vegetables rich in folic 
acid such as spinach, okra, beans, lentils and avocado regularly. 
Intake varied during the year depending on the season and 
availability. None of the women had heard about food fortification or 
recognized the signs on available food products. Of the women 
taking folic acid, 75.5% (149/197) said folic acid (in 5mg tablets) 
was available at the health facility during their visits. The other 
24.5% (46) said sometimes stock outs occurred. Those who had 
access to folic acid at the health facility were more likely to take it 
(p<0.001). Women attending health education at the health 
facilities were more likely to take folic acid compared to those who 
did not receive health education (p<0.001). 
  
All health workers interviewed had ever heard of spina bifida. The 
majority of the health workers, 80% (28/35), believed folic acid 
intake and good antenatal care could prevent spina bifida, 9% 
(3/35) believed there is no prevention, while 11% (4/35) were not 
aware of any. Of those who believed folic acid intake could prevent 
spina bifida (28/35), 7% (2/35) said it should be taken before 
pregnancy and early weeks of pregnancy, 25% (7/35) said 
preferably before birth or as soon as the woman realizes she is 
pregnant for a period of 90 days, 39% (11/35) recommended folic 
acid use (5mg tablets once a day) throughout pregnancy, and 29% 
(8/35) health workers recommended folic acid use in only the 
second and third trimester. All health workers felt that intake of folic 
acid was important for the babies general development, and 
mother's health. A fifth (7/35) of the health workers said folic acid is 
not always available at the health facility they work at. None of the 
health workers had heard about food fortification. 
  
  
 
 
Discussion 
 
Our findings show that knowledge about the preventative effect of 
folic acid on spina bifida, and folate intake before and during the 
first weeks of pregnancy is very limited in northern Uganda. 
Awareness of spina bifida (33.5%) in women attending ANC was in 
line with earlier studies, e.g. 25.5% in Nigeria [29], and 53% in 
Congo [30]. With 17.3% of the Ugandan women in our study taking 
folic acid supplements during the first trimester of pregnancy, the 
percentage is slightly lower than the worldwide estimate of only 
20% of pregnant women being able to follow the recommendation 
of folic acid intake for prevention [31]. Whilst peri-conceptional 
intake of folic acid supplements was 17.2% in Tanzania [32], our 
study population did not report any early intake of supplements. 
Women did report to regularly consume foods rich in folic acid. One 
of the limitations of our study is that it could not define the amounts 
consumed, as no food samples or biomedical investigations were 
conducted. The lack of folic acid intake in northern Uganda could 
partially be explained by the lack of knowledge on the importance of 
intake prior to and in the first 28 days of pregnancy amongst the 
health workers interviewed. Health workers in our study had 
knowledge about the importance of folic acid intake during 
pregnancy but not about the crucial pre-conceptual and early 
conceptual period, they were also not aware of the recommended 
dosage too. 
  
Sensitization of health workers and women in reproductive age is 
key to encourage early ANC attendance and folic acid intake. 
Alongside sensitization at the antenatal clinic, women should receive 
sexual and reproductive health education from an early age. 
Following the conflict, educational attainment has been lacking in 
the northern region, and girls secondary school completion remains 
low [33]. Counseling on folic acid use in the media and marriage 
counseling may be considered to inform young couples as many will 
not have received formal sexual and reproductive health education. 
In Congo patient education through video media increased 
awareness and knowledge of spina bifida and folic acid [30]. In 
northern Uganda mobile video media could be explored. Radio 
messages have proven powerful in transferring health messages in 
the region and could also be used [34-36]. 
  
To improve access to folic acid supplements, there is need to 
strengthen the supply chain and address stock outs, so that folic 
acid supplements are provided at the first antenatal visit, or ideally 
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to all women in child bearing age. Gulu district health facilities had a 
57% basic drug stock out in 2012 [27]. Aside assuring folic acid 
stocks in health facilities, we recommend sensitization on the correct 
dosage. In a Uganda a huge difference was found between and 
within districts in the dosage of folic acid provided to pregnant 
women [37]. The differences were not only caused by lack of 
supplies but also by health worker's lack of knowledge on updated 
guidelines. During the war health structures in northern Uganda 
dilapidated and health workers in the area may not have received 
the necessary training, resulting in knowledge gaps. With targeted 
recovery plans of the Ugandan Government, supported by donors, 
and national guidelines from the Ministry of Health, the health 
system is recovering and targets are set to improve maternal and 
child health [22, 38, 39]. Whilst educating health workers on the 
correct dosage, supplies of 400mcg rather than 5mg tablets should 
be availed by the National Medical Stores to enable health workers 
provide the correct preventative dosage, as 1mg and not 5mg is the 
upper tolerable daily limit [40]. 
  
Together with improving folic acid supplementation, we argue for 
mandatory food fortification and implementation of this process at 
national level to increase levels of folic acid intake for all women in 
childbearing age. Participants in our study were not familiar with 
food fortification. Globally 25% of folic acid-preventable spina bifida 
is being prevented, and mandatory food fortification is 
recommended to achieve total prevention [41]. Sensitization about 
food fortification and recognition of the label can increase use of 
fortified foods. In South Africa folic acid fortification of staple foods 
reduced the prevalence of spina bifida with 41.6%, benefits 
outweighed the costs of food fortification [42]. It should be noted 
that not all women in reproductive age will benefit from food 
fortification, as many are subsistent farmers and are more likely to 
feed from their own produce than goods sold on the markets. We 
recommend further studies involving women prior to conception, 
during pregnancy and after birth with frequent measurements of 
folic acid intake to understand the actual levels of folic acid intake in 
the population, and evaluation studies to measure possible effects 
of sensitization campaigns and training of health workers in future. 
  
  
Conclusion 
 
Folic acid intake is limited in northern Uganda. This is attributed to 
limited education and understanding of women and health workers 
about the importance of early folic acid intake, late presentation of 
women at ANC, poor supply chain and dilapidated health services 
caused by war and poverty. A combination of food fortification, 
sensitization of health workers, women, and improving folic acid 
supply is recommended to reduce the number of children born with 
neural tube defects such as spina bifida. 
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Table 1: Demographic characteristics respondents northern Uganda 
Characteristics 
Mothers of children with spina 
bifida (N=15) 
Women attending antenatal 
clinics (N=394) 
Health workers in antenatal 
clinics 
(N=35) 
Age (mean) 31 (range 22 – 36) 29 years (range 18 – 40, SD 7.8) 28 years (range 22 – 42) 
Marital status 
6.7% (1) single, 60% 
  (9) married, 13.3% (2) 
 separated, 20% (3) 
 widowed 
19% (75) single, 72.2%   
(284) married, 5% (20)  
separated, 3.8% (15)  
widowed 
11.4% (4) single,   
88.6% (31) married 
  
  
Number of children 4.2 mean (range 1 – 8) 3.8 children (range 0 - 9) 3.1 mean (0 – 6) 
Education 
26.6 % (4) never went 
 to school, 60.0% 
 completed primary (9), 
 6.7% (1) completed 
 secondary, 6.7% (1) 
 higher education 
15.8% (63) never went to  
school, 55.6% (219)  
completed primary, 22.4%  
(88) completed secondary,  
6.2% (24) higher education  
  
54% (19) nursing -  
enrolled, 11% (4)  
registered nursing -  
registered, 35% (12)  
midwifery 
  
Religion 
86.7% (13) Christian 
13.3% (2) Muslim 
97% (382) Christian 
3% (12) Muslim 
98% (34) Christian 
2% (1) Muslim 
Occupation 
73.2% (11) peasant 
 farmers, 13.4% (2) 
 petty traders, 13.4% 
 (2) others 
44.7% (176) peasant  
farmers, 39.9% (157) petty  
traders, 15.5% (61) others 
  
54% (19) enrolled  
nurse, 11% (4)  
registered nurse,  
35% (12) midwife 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2: Folic acid intake in mothers of children with spina bifida and women attending ANC in northern Uganda 
Started taking FA 
Mother of children with 
spina bifida 
Women attending 
antenatal care 
Before conception 0% (0) 0% (0) 
During pregnancy (first trimester) 0% (0) 8.1% (32) 
During pregnancy (2nd and 3rd trimester) 26.7% (4) 42.4% (167) 
Did not take FA (11) 49.5% (195) 
Page number not for citation purposes 9 
 
 Table 3: Factors associated with folic acid intake in women attending ANC in northern Uganda 
Factors 
 
Folic Acid Intake 
  
  
Yes No N (total) χ 2 
Knowledge of spina bifida Yes 91 (45.5) 41 (21.1) 132 (33.5) 26.24* 
 
No 109 (54.5) 153 (78.9) 262 (66.5) 
 
Availability of drugs Yes 168 (87.0) 121 (63.7) 289 (75.5) 28.22* 
 
No 25 (13.0) 69 (36.3) 94 (24.5) 
 
Health education  Yes 52 (25.7) 13 (6.6) 65 (16.3) 26.59* 
  No 150 (74.3) 183 (93.4) 333 (83.7) 
 
p<0.001 
